Tempest TherapeuticsTPST
13F holders, Q1 2025 (March 31)22holders −13
1new positions
13sold out
$0.74avg. 13F price*
At the end of Q1 2025, 22 institutions reported holding Tempest Therapeutics Inc. (TPST) in their 13F filings, down 13 from Q4 2024. 1 opened new positions and 13 sold out. The largest holders were BlackRock, Inc. ($414K), Geode Capital Management, LLC ($320K) and FMR LLC ($319K).
- Company
- Tempest Therapeutics Inc.
- CUSIP
- 87978U108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $57 |
| Exits | 13 | $3.9M |
All 13F filers, Q4 2024 → Q1 2025: 396,096 shares bought and 4,697,894 shares sold, net −4,301,798 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 22 holders
| BlackRock, Inc. | 0.00% | Add +1.8% | 561,503 | $414K |
| Geode Capital Management, LLC | 0.00% | Add +22.3% | 433,346 | $320K |
| FMR LLC | 0.00% | No change | 431,932 | $319K |
| UBS Group AG | 0.00% | Add +65.4% | 323,699 | $239K |
| Vanguard Group Inc. | 0.00% | Add +69.1% | 297,877 | $220K |
| Susquehanna International Group, LLP | 0.00% | Reduce -7.2% | 114,559 | $85K |
| Northern Trust Corp. | 0.00% | Add +46.6% | 99,391 | $73K |
| DAVENPORT & Co LLC | 0.00% | No change | 50,000 | $37K |
| Morgan Stanley | 0.00% | Add +48.4% | 44,465 | $33K |
| State Street Corp. | 0.00% | No change | 41,492 | $31K |
| Osaic Holdings, Inc. | 0.00% | No change | 25,722 | $19K |
| Simplex Trading, LLC | 0.00% | Add +8.0% | 20,422 | $15K |
| National Bank of Canada | 0.00% | Add +100.0% | 20,000 | $15K |
| MayTech Global Investments, LLC | 0.00% | No change | 10,000 | $7K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 3,800 | $3K |
| Millstone Evans Group, LLC | 0.00% | No change | 800 | $590 |
| Bank of America Corp. | 0.00% | Add +5.4% | 349 | $258 |
| Parallel Advisors, LLC | 0.00% | Add +0.4% | 236 | $174 |
| CIBC Private Wealth Group LLC | 0.00% | No change | 133 | $67 |
| JPMorgan Chase & Co. | 0.00% | New | 77 | $57 |
| BNP Paribas Financial Markets | 0.00% | No change | 48 | $35 |
| Royal Bank of Canada | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is TPST's weight in each manager's 13F, not the share of Tempest Therapeutics Inc. the manager owns.